Meningitis

• CLINICAL_TRIALS trial_result · 2009-11-25
  Clinical Trial Update: Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune® [Phase 2]

  Phase 2 trial evaluating the persistence of antibodies in children aged 7 to 15 years after a single dose of Menactra or Menomune; results w…

• CLINICAL_TRIALS trial_result · 2009-07-13
  Clinical Trial Update: Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) [Phase 3]

  Phase 3 trial evaluating the safety of administering Gardasil concurrently with a combined Diphtheria/Tetanus/Pertussis vaccine and a Mening…

• FDA approval · 2009-06-18
  FDA Approved: CEFTRIAXONE — Supplemental Application (Baxter Healthcare Company)

  FDA approved a supplemental application for ceftriaxone sodium (ceftriaxone) from Baxter Healthcare Company, authorizing changes to the appr…

• CLINICAL_TRIALS trial_result · 2009-05-14
  Clinical Trial Update: Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine [Phase 2]

  Phase 2 trial evaluating a reduced dose of Menomune in children who previously received meningococcal-conjugate vaccine; completed with resu…

• CLINICAL_TRIALS trial_result · 2009-04-30
  Clinical Trial Update: Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune® [Phase 4]

  Phase 4 clinical trial assesses safety and immunogenicity of intradermal versus subcutaneous dosing of Menomune for meningococcal infections…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2009-04-24
  Clinical Trial Update: Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children [Phase 2]

  Phase 2 study evaluating antibody responses after a dose of a tetravalent meningococcal diphtheria conjugate vaccine in children; results we…

• CLINICAL_TRIALS trial_result · 2009-03-19
  Clinical Trial Update: Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents [Phase 2]

  A Phase 2 trial evaluated a booster dose of the meningococcal diphtheria toxoid conjugate vaccine in adolescents; results were posted after …

• CLINICAL_TRIALS trial_result · 2008-08-08
  Clinical Trial Update: Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection [Phase 4]

  This Phase 4 trial assessed the immunogenicity of the 7-valent pneumococcal conjugate vaccine in the lung fluid of adults with and without H…

• FDA approval · 2008-03-20
  FDA Approved: CEFEPIME — Original Application (Sagent Pharmaceuticals)

  FDA records the original approval of cefepime hydrochloride (cefepime) for Sagent Pharmaceuticals under an ANDA. The approval concerns a bro…

• CLINICAL_TRIALS trial_result · 2007-03-19
  Clinical Trial Update: Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage [Phase 4]

  Phase 4 study evaluating the effect of a meningococcal conjugate vaccine on meningococcal carriage has completed.